FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:PDGFRL-VPS37A

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: PDGFRL-VPS37A
FusionPDB ID: 63864
FusionGDB2.0 ID: 63864
HgeneTgene
Gene symbol

PDGFRL

VPS37A

Gene ID

5157

137492

Gene nameplatelet derived growth factor receptor likeVPS37A subunit of ESCRT-I
SynonymsPDGRL|PRLTSHCRP1|PQBP2|SPG53
Cytomap

8p22

8p22

Type of geneprotein-codingprotein-coding
Descriptionplatelet-derived growth factor receptor-like proteinPDGF receptor beta-like tumor suppressorPDGFR-like proteinplatelet-derived growth factor-beta-like tumor suppressorvacuolar protein sorting-associated protein 37AESCRT-I complex subunit VPS37AVPS37A, ESCRT-I subunithepatocellular carcinoma-related protein 1polyglutamine binding protein 2vacuolar protein sorting 37 homolog A
Modification date2020031320200313
UniProtAcc..
Ensembl transtripts involved in fusion geneENST idsENST00000251630, ENST00000398074, 
ENST00000541323, ENST00000523248, 
ENST00000324815, ENST00000521005, 
ENST00000521162, ENST00000521829, 
ENST00000324849, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score2 X 2 X 2=85 X 6 X 4=120
# samples 26
** MAII scorelog2(2/8*10)=1.32192809488736log2(6/120*10)=-1
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: PDGFRL [Title/Abstract] AND VPS37A [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: PDGFRL [Title/Abstract] AND VPS37A [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)PDGFRL(17447274)-VPS37A(17132242), # samples:3
Anticipated loss of major functional domain due to fusion event.PDGFRL-VPS37A seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
PDGFRL-VPS37A seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
PDGFRL-VPS37A seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
PDGFRL-VPS37A seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr8:17447274/chr8:17132242)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across PDGFRL (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across VPS37A (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000541323PDGFRLchr817447274+ENST00000324849VPS37Achr817132242+46147983851575396
ENST00000251630PDGFRLchr817447274+ENST00000324849VPS37Achr817132242+4610794631571502
ENST00000398074PDGFRLchr817447274+ENST00000324849VPS37Achr817132242+423041411191396

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000541323ENST00000324849PDGFRLchr817447274+VPS37Achr817132242+9.26E-050.9999074
ENST00000251630ENST00000324849PDGFRLchr817447274+VPS37Achr817132242+0.0004726040.99952745
ENST00000398074ENST00000324849PDGFRLchr817447274+VPS37Achr817132242+8.63E-050.9999137

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for PDGFRL-VPS37A

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
PDGFRLchr817447274VPS37Achr817132242414137YPAYLDTFKDSRLSLYSNPSGMSPYA
PDGFRLchr817447274VPS37Achr817132242794243YPAYLDTFKDSRLSLYSNPSGMSPYA
PDGFRLchr817447274VPS37Achr817132242798137YPAYLDTFKDSRLSLYSNPSGMSPYA

Top

Potential FusionNeoAntigen Information of PDGFRL-VPS37A in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
PDGFRL-VPS37A_17447274_17132242.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
PDGFRL-VPS37Achr817447274chr817132242794HLA-B14:01FKDSRLSL0.99870.6464715
PDGFRL-VPS37Achr817447274chr817132242794HLA-B14:02FKDSRLSL0.99870.6464715
PDGFRL-VPS37Achr817447274chr817132242794HLA-B14:02TFKDSRLSL0.99280.589615
PDGFRL-VPS37Achr817447274chr817132242794HLA-B14:01TFKDSRLSL0.99280.589615
PDGFRL-VPS37Achr817447274chr817132242794HLA-B15:18FKDSRLSLY0.52110.703716
PDGFRL-VPS37Achr817447274chr817132242794HLA-B15:03FKDSRLSLY0.48310.7472716
PDGFRL-VPS37Achr817447274chr817132242794HLA-B39:09FKDSRLSL0.99970.5613715
PDGFRL-VPS37Achr817447274chr817132242794HLA-B39:12FKDSRLSL0.99970.869715
PDGFRL-VPS37Achr817447274chr817132242794HLA-B39:05FKDSRLSL0.99930.8396715
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:13FKDSRLSL0.9980.9221715
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:29FKDSRLSL0.99720.9434715
PDGFRL-VPS37Achr817447274chr817132242794HLA-B14:03FKDSRLSL0.87240.7373715
PDGFRL-VPS37Achr817447274chr817132242794HLA-C12:16TFKDSRLSL0.97940.9533615
PDGFRL-VPS37Achr817447274chr817132242794HLA-B73:01SRLSLYSNP0.96450.59581019
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:95FKDSRLSLY0.90730.6119716
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:27FKDSRLSLY0.89870.9128716
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:19FKDSRLSLY0.88320.5038716
PDGFRL-VPS37Achr817447274chr817132242794HLA-B14:03TFKDSRLSL0.80640.703615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:67FKDSRLSLY0.80470.8829716
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:80FKDSRLSLY0.80470.8829716
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:46FKDSRLSLY0.79850.7374716
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:05FKDSRLSLY0.78360.8887716
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:10FKDSRLSLY0.74870.9357716
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:05TFKDSRLSL0.72510.9537615
PDGFRL-VPS37Achr817447274chr817132242794HLA-B15:21FKDSRLSLY0.70690.8863716
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:13TFKDSRLSL0.64240.9345615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:46TFKDSRLSL0.6150.8475615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C04:14TFKDSRLSL0.60720.678615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:29TFKDSRLSL0.60360.9424615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:27TFKDSRLSL0.59110.9457615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:10TFKDSRLSL0.59020.9563615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:67TFKDSRLSL0.58430.9254615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:80TFKDSRLSL0.58430.9254615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:19TFKDSRLSL0.57330.627615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:95TFKDSRLSL0.56220.7164615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C01:30TFKDSRLSL0.44150.9607615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C12:16FKDSRLSLY0.02530.9579716
PDGFRL-VPS37Achr817447274chr817132242794HLA-C18:01FKDSRLSL0.99990.7074715
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:04FKDSRLSL0.99810.9012715
PDGFRL-VPS37Achr817447274chr817132242794HLA-C03:67FKDSRLSL0.99710.9758715
PDGFRL-VPS37Achr817447274chr817132242794HLA-B39:11FKDSRLSL0.99560.679715
PDGFRL-VPS37Achr817447274chr817132242794HLA-B15:09FKDSRLSL0.99230.6785715
PDGFRL-VPS37Achr817447274chr817132242794HLA-C18:01FKDSRLSLY0.96760.6513716
PDGFRL-VPS37Achr817447274chr817132242794HLA-C06:02TFKDSRLSL0.95880.983615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C06:17TFKDSRLSL0.95880.983615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:01FKDSRLSLY0.9290.5803716
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:02FKDSRLSLY0.80470.8829716
PDGFRL-VPS37Achr817447274chr817132242794HLA-C03:67TFKDSRLSL0.80370.9714615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:22TFKDSRLSL0.77490.7712615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C06:08TFKDSRLSL0.75090.9738615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:17FKDSRLSLY0.74470.9611716
PDGFRL-VPS37Achr817447274chr817132242794HLA-C06:06TFKDSRLSL0.71920.9841615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:17TFKDSRLSL0.69510.9481615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:04TFKDSRLSL0.67790.88615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:22FKDSRLSLY0.6730.6997716
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:02TFKDSRLSL0.58430.9254615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C04:04TFKDSRLSL0.57940.7094615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C07:01TFKDSRLSL0.5660.6639615
PDGFRL-VPS37Achr817447274chr817132242794HLA-B48:02FKDSRLSLY0.47780.9126716
PDGFRL-VPS37Achr817447274chr817132242794HLA-C14:02TFKDSRLSL0.47440.9547615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C14:03TFKDSRLSL0.47440.9547615
PDGFRL-VPS37Achr817447274chr817132242794HLA-C06:06FKDSRLSLY0.45230.988716
PDGFRL-VPS37Achr817447274chr817132242794HLA-B15:54FKDSRLSLY0.03190.8775716
PDGFRL-VPS37Achr817447274chr817132242794HLA-B15:68FKDSRLSLY0.01530.5961716
PDGFRL-VPS37Achr817447274chr817132242794HLA-C12:02FKDSRLSLY0.00650.9643716
PDGFRL-VPS37Achr817447274chr817132242794HLA-A25:01DTFKDSRLSL0.98760.8249515
PDGFRL-VPS37Achr817447274chr817132242794HLA-A69:01DTFKDSRLSL0.81350.5556515
PDGFRL-VPS37Achr817447274chr817132242794HLA-C14:02TFKDSRLSLY0.73070.9324616
PDGFRL-VPS37Achr817447274chr817132242794HLA-C14:03TFKDSRLSLY0.73070.9324616
PDGFRL-VPS37Achr817447274chr817132242794HLA-A25:01DTFKDSRLSLY0.99920.6971516

Top

Potential FusionNeoAntigen Information of PDGFRL-VPS37A in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
PDGFRL-VPS37A_17447274_17132242.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
PDGFRL-VPS37Achr817447274chr817132242794DRB1-0473DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-0473KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1501DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1501KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1501SRLSLYSNPSGMSPY1025
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1501FKDSRLSLYSNPSGM722
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1502DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1503DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1504DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1504KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1505DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1505KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1506DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1506KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1506SRLSLYSNPSGMSPY1025
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1506FKDSRLSLYSNPSGM722
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1507DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1507KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1507SRLSLYSNPSGMSPY1025
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1507FKDSRLSLYSNPSGM722
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1508DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1509DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1509KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1509SRLSLYSNPSGMSPY1025
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1509FKDSRLSLYSNPSGM722
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1510DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1511DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1512DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1513DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1513KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1513SRLSLYSNPSGMSPY1025
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1513FKDSRLSLYSNPSGM722
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1514DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1515DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1516DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1516KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1516SRLSLYSNPSGMSPY1025
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1516FKDSRLSLYSNPSGM722
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1518DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1518KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1519DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1520DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1520KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1520SRLSLYSNPSGMSPY1025
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1520FKDSRLSLYSNPSGM722
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1522DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1522KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1522SRLSLYSNPSGMSPY1025
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1522FKDSRLSLYSNPSGM722
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1523DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1524DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1524KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1524SRLSLYSNPSGMSPY1025
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1524FKDSRLSLYSNPSGM722
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1526DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1528DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1528KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1531DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1532DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1532KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1532SRLSLYSNPSGMSPY1025
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1532FKDSRLSLYSNPSGM722
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1533DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1533KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1533SRLSLYSNPSGMSPY1025
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1533FKDSRLSLYSNPSGM722
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1535DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1535KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1536DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1536KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1536SRLSLYSNPSGMSPY1025
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1536FKDSRLSLYSNPSGM722
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1537DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1537KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1538DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1539DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1540DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1540KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1540SRLSLYSNPSGMSPY1025
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1540FKDSRLSLYSNPSGM722
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1541DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1541KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1541SRLSLYSNPSGMSPY1025
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1541FKDSRLSLYSNPSGM722
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1542DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1542KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1542SRLSLYSNPSGMSPY1025
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1542FKDSRLSLYSNPSGM722
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1543DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1543KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1543SRLSLYSNPSGMSPY1025
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1543FKDSRLSLYSNPSGM722
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1544DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1545DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1545KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1545SRLSLYSNPSGMSPY1025
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1545FKDSRLSLYSNPSGM722
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1546DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1546KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1546SRLSLYSNPSGMSPY1025
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1546FKDSRLSLYSNPSGM722
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1547DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1548DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1548KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1548SRLSLYSNPSGMSPY1025
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1548FKDSRLSLYSNPSGM722
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1549DSRLSLYSNPSGMSP924
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1549KDSRLSLYSNPSGMS823
PDGFRL-VPS37Achr817447274chr817132242794DRB1-1549SRLSLYSNPSGMSPY1025
PDGFRL-VPS37Achr817447274chr817132242794DRB3-0201RLSLYSNPSGMSPYA1126
PDGFRL-VPS37Achr817447274chr817132242794DRB3-0204RLSLYSNPSGMSPYA1126
PDGFRL-VPS37Achr817447274chr817132242794DRB3-0205RLSLYSNPSGMSPYA1126
PDGFRL-VPS37Achr817447274chr817132242794DRB3-0214RLSLYSNPSGMSPYA1126
PDGFRL-VPS37Achr817447274chr817132242794DRB3-0224RLSLYSNPSGMSPYA1126

Top

Fusion breakpoint peptide structures of PDGFRL-VPS37A

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
9328TFKDSRLSLYSNPSPDGFRLVPS37Achr817447274chr817132242794

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of PDGFRL-VPS37A

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN9328TFKDSRLSLYSNPS-7.9962-8.1096
HLA-B14:023BVN9328TFKDSRLSLYSNPS-5.70842-6.74372
HLA-B52:013W399328TFKDSRLSLYSNPS-6.83737-6.95077
HLA-B52:013W399328TFKDSRLSLYSNPS-4.4836-5.5189
HLA-A11:014UQ29328TFKDSRLSLYSNPS-10.0067-10.1201
HLA-A11:014UQ29328TFKDSRLSLYSNPS-9.03915-10.0745
HLA-A24:025HGA9328TFKDSRLSLYSNPS-6.56204-6.67544
HLA-A24:025HGA9328TFKDSRLSLYSNPS-5.42271-6.45801
HLA-B44:053DX89328TFKDSRLSLYSNPS-7.85648-8.89178
HLA-B44:053DX89328TFKDSRLSLYSNPS-5.3978-5.5112
HLA-A02:016TDR9328TFKDSRLSLYSNPS-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of PDGFRL-VPS37A

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
PDGFRL-VPS37Achr817447274chr8171322421019SRLSLYSNPTCGCCTCAGTCTATACAGTAACCCAAG
PDGFRL-VPS37Achr817447274chr817132242515DTFKDSRLSLCACCTTTAAGGATTCTCGCCTCAGTCTATA
PDGFRL-VPS37Achr817447274chr817132242516DTFKDSRLSLYCACCTTTAAGGATTCTCGCCTCAGTCTATACAG
PDGFRL-VPS37Achr817447274chr817132242615TFKDSRLSLCTTTAAGGATTCTCGCCTCAGTCTATA
PDGFRL-VPS37Achr817447274chr817132242616TFKDSRLSLYCTTTAAGGATTCTCGCCTCAGTCTATACAG
PDGFRL-VPS37Achr817447274chr817132242715FKDSRLSLTAAGGATTCTCGCCTCAGTCTATA
PDGFRL-VPS37Achr817447274chr817132242716FKDSRLSLYTAAGGATTCTCGCCTCAGTCTATACAG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
PDGFRL-VPS37Achr817447274chr8171322421025SRLSLYSNPSGMSPYTCGCCTCAGTCTATACAGTAACCCAAGTGGGATGTCTCCTTATGC
PDGFRL-VPS37Achr817447274chr8171322421126RLSLYSNPSGMSPYACCTCAGTCTATACAGTAACCCAAGTGGGATGTCTCCTTATGCTTC
PDGFRL-VPS37Achr817447274chr817132242722FKDSRLSLYSNPSGMTAAGGATTCTCGCCTCAGTCTATACAGTAACCCAAGTGGGATGTC
PDGFRL-VPS37Achr817447274chr817132242823KDSRLSLYSNPSGMSGGATTCTCGCCTCAGTCTATACAGTAACCCAAGTGGGATGTCTCC
PDGFRL-VPS37Achr817447274chr817132242924DSRLSLYSNPSGMSPTTCTCGCCTCAGTCTATACAGTAACCCAAGTGGGATGTCTCCTTA

Top

Information of the samples that have these potential fusion neoantigens of PDGFRL-VPS37A

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
LUADPDGFRL-VPS37Achr817447274ENST00000251630chr817132242ENST00000324849TCGA-91-A4BC-01A

Top

Potential target of CAR-T therapy development for PDGFRL-VPS37A

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to PDGFRL-VPS37A

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to PDGFRL-VPS37A

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource